Debiopharm taps ViewsML AI-driven platform to streamline biomarker detection in oncology research. VANCOUVER, BRITISH COLUMBIA, CANADA, June 17, 2025 /EINPresswire.com/ -- ViewsML, a techbio company specializing in AI-driven virtual...

Powered by Lunit SCOPE PD-L1, the Guardant360 TissueNext PD-L1 test with Guardant Galaxy™ shows improved detection of the biomarker in NSCLC Lunit's AI solution is the first application in Guardant Galaxy, a suite of AI and other...

Paige: First European regulatory clearance for Paige’s digital biomarker capabilities NEW YORK--(BUSINESS WIRE)--Paige, a global leader in clinical AI applications in pathology, today announced it received CE-IVD and UKCA marks for the...

It enables every actor in Pathology to run digital image analysis in the context of clinical trials, as in CAP/CLIA laboratories, with unprecedented efficiency. This AI-platform strengthens Keen Eye's strategic positioning in the clinical...

The CE-IVD marked AI model for Ki67 is the first model to be released as part of the Aiforia Clinical Suite for Breast Cancer, supporting pathologists in cancer diagnosis. First-of-its kind diagnostic tool Aiforia today announced the CE-IVD...